New drug KIVU-107 enters first human tests for hard-to-treat cancers
NCT ID NCT07229313
First seen Nov 16, 2025 · Last updated May 01, 2026 · Updated 17 times
Summary
This early-stage study tests a new drug, KIVU-107, in about 76 adults with advanced solid tumors that have not responded to standard treatments. The drug is designed to target and attack cancer cells. The main goal is to find a safe dose and check for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kivu Trial Site
RECRUITINGSanta Monica, California, 90403, United States
-
Kivu Trial Site
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Kivu Trial Site
RECRUITINGSydney, New South Wales, Australia
-
Kivu Trial Site
RECRUITINGBrisbane, Queensland, Australia
-
Kivu Trial Site
RECRUITINGAdelaide, South Australia, Australia
-
Kivu Trial Site
RECRUITINGGeelong, Victoria, Australia
Conditions
Explore the condition pages connected to this study.